These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2532753)

  • 1. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
    Psychiatry Res; 1989 Sep; 29(3):361-2. PubMed ID: 2532753
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
    Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE
    Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral involvement in systemic lupus erythematosus (SLE): comparison of positron emission tomography (PET) with other imaging methods.
    Meyer GJ; Schober O; Stoppe G; Wildhagen K; Seidel JW; Hundeshagen H
    Psychiatry Res; 1989 Sep; 29(3):367-8. PubMed ID: 2608795
    [No Abstract]   [Full Text] [Related]  

  • 6. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET and neuropsychology in thalamic infarction: evidence for associated cortical dysfunction.
    Hennerici M; Halsband U; Kuwert T; Steinmetz H; Herzog H; Aulich A; Feinendegen LE
    Psychiatry Res; 1989 Sep; 29(3):363-5. PubMed ID: 2608794
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic problems in juvenile Huntington chorea].
    Woldag H; Strenge S; Weise K
    Nervenarzt; 1997 Aug; 68(8):667-70. PubMed ID: 9380214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
    Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
    Nagel JS; Johnson KA; Ichise M; English RJ; Walshe TM; Morris JH; Holman BL
    Clin Nucl Med; 1988 Jul; 13(7):486-90. PubMed ID: 2971497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical glucose metabolism in Huntington's disease.
    Martin WR; Clark C; Ammann W; Stoessl AJ; Shtybel W; Hayden MR
    Neurology; 1992 Jan; 42(1):223-9. PubMed ID: 1531155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
    Kuhl DE; Metter EJ; Riege WH; Markham CH
    Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of size of regions of interest on PET evaluation of caudate glucose consumption.
    Kuwert T; Ganslandt T; Jansen P; Jülicher F; Lange H; Herzog H; Scholz D; Aulich A; Feinendegen LE
    J Comput Assist Tomogr; 1992; 16(5):789-94. PubMed ID: 1387888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
    Brain; 1990 Oct; 113 ( Pt 5)():1405-23. PubMed ID: 2147116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.
    Reid IC; Besson JA; Best PV; Sharp PF; Gemmell HG; Smith FW
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1264-8. PubMed ID: 2976081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.